Holy O, Matouskova I
Contemp Oncol (Pozn). 2013; 16(3):266-72.
PMID: 23788892
PMC: 3687407.
DOI: 10.5114/wo.2012.29298.
Drahota A, Ward D, Mackenzie H, Stores R, Higgins B, Gal D
Cochrane Database Syst Rev. 2012; (3):CD005315.
PMID: 22419308
PMC: 6464891.
DOI: 10.1002/14651858.CD005315.pub2.
Johnston D, Bodey G
Appl Microbiol. 1970; 20(2):218-23.
PMID: 5529632
PMC: 376904.
DOI: 10.1128/am.20.2.218-223.1970.
CORIELL L, McGarrity G
Appl Microbiol. 1970; 20(3):474-9.
PMID: 5485728
PMC: 376962.
DOI: 10.1128/am.20.3.474-479.1970.
Van Der Waaij D, Andreas A
J Hyg (Lond). 1971; 69(1):83-9.
PMID: 5291754
PMC: 2130844.
DOI: 10.1017/s0022172400021276.
Microbiological evaluation of protected environments during patient occupancy.
Bodey G, Johnston D
Appl Microbiol. 1971; 22(5):828-36.
PMID: 4943588
PMC: 376428.
DOI: 10.1128/am.22.5.828-836.1971.
Procedures to reduce contamination of cell cultures.
McGarrity G, CORIELL L
In Vitro. 1971; 6(4):257-65.
PMID: 4943220
DOI: 10.1007/BF02625938.
Laminar airflow protection in bone marrow transplantation.
SOLBERG C, Matsen J, Vesley D, Wheeler D, GOOD R, Meuwissen H
Appl Microbiol. 1971; 21(2):209-16.
PMID: 4927401
PMC: 377151.
DOI: 10.1128/am.21.2.209-216.1971.
Oral antibiotic prophylaxis in protected environment units: effect of nonabsorbable and absorbable antibiotics on the fecal flora.
Bodey G
Antimicrob Agents Chemother. 1972; 1(4):343-7.
PMID: 4670698
PMC: 444219.
DOI: 10.1128/AAC.1.4.343.
Oropharyngeal cultures of patients in protected environment units: evaluation of semiquantitative technique during antibiotic prophylaxis.
Johnston D, Bodey G
Appl Microbiol. 1972; 23(5):846-51.
PMID: 4555635
PMC: 380459.
DOI: 10.1128/am.23.5.846-851.1972.
[Clinical gnotobiotics in hematology].
Dietrich M
Blut. 1974; 28(5):317-20.
PMID: 4422434
DOI: 10.1007/BF01631518.
Microbial skin flora of selected cancer patients and hospital personnel.
McBride M, Duncan W, Bodey G, McBride C
J Clin Microbiol. 1976; 3(1):14-20.
PMID: 943418
PMC: 274219.
DOI: 10.1128/jcm.3.1.14-20.1976.
Isolating patients in hospital to control infection. Part III--Design and construction of isolation accommodation.
Bagshawe K, Blowers R, LIDWELL O
Br Med J. 1978; 2(6139):744-8.
PMID: 698706
PMC: 1607595.
DOI: 10.1136/bmj.2.6139.744.
Concentrations of nystatin in faeces after oral administration of various doses of nystatin.
Hofstra W, de Vries-Hospers H, Van Der Waaij D
Infection. 1979; 7(4):166-70.
PMID: 511333
DOI: 10.1007/BF01640934.
Clinical use of reverse isolation in a protected environment.
Blaha M, Vanasek J, MERKA V, Splino M, Maly J, Siroky O
Folia Microbiol (Praha). 1979; 24(1):88-95.
PMID: 437588
DOI: 10.1007/BF02927247.
Marrow transplantation of aplastic anemia and acute leukemia.
Thomas E, Weiden P
World J Surg. 1977; 2(1):197-206.
PMID: 17234
DOI: 10.1007/BF01665082.
